Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Author:
Affiliation:
1. Oslo University Hospital; Department of Internal Medicine; Oslo Norway NO-0407
Publisher
Wiley
Subject
Pharmacology (medical)
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008980.pub3/epdf/full
Reference72 articles.
1. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial;The Amadeus Investigators;Lancet,2008
2. Apixaban versus warfarin in patients with atrial fibrillation;Granger;New England Journal of Medicine,2011
3. Safety and efficacy of the oral direct factor Xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation;Ogawa;Circulation Journal,2011
4. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study;Buller;Journal of Thrombosis and Haemostasis,2014
5. Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation;Chung;Thrombosis and Haemostasis,2011
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries;Stroke and Vascular Neurology;2024-02-08
2. Was ist gesichert in der Therapie des ischämischen Schlaganfalls?;Die Innere Medizin;2023-11-10
3. An Inconspicuous Offender: Apixaban-Induced Anticoagulant-Related Nephropathy;Cureus;2023-09-04
4. A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States;American Journal of Cardiovascular Drugs;2023-06-10
5. Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case–control study;BMC Cardiovascular Disorders;2023-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3